On Invalid Date, Atea Pharmaceuticals (NASDAQ: AVIR) reported Q4 2023 earnings per share (EPS) of -$0.47, up 14.63% year over year. Total Atea Pharmaceuticals earnings for the quarter were -$39.16 million. In the same quarter last year, Atea Pharmaceuticals's earnings per share (EPS) was -$0.41.
As of Q2 2024, Atea Pharmaceuticals's earnings has grown year over year. Atea Pharmaceuticals's earnings in the past year totalled -$135.96 million.
What is AVIR's earnings date?
Atea Pharmaceuticals's earnings date is Invalid Date. Add AVIR to your watchlist to be reminded of AVIR's next earnings announcement.
What was AVIR's revenue last quarter?
On Invalid Date, Atea Pharmaceuticals (NASDAQ: AVIR) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Atea Pharmaceuticals's revenue was $0.00.
What was AVIR's revenue growth in the past year?
As of Q2 2024, Atea Pharmaceuticals's revenue has grown null year over year. Atea Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.